Posted On: 10/12/2014 11:30:25 AM
Post# of 30070
Re: biotechexpert #8452
Ponder this expert (wink)..
In the end ambs will be truly valued on a multiple of revenue + a fair price for milestones on assets which eventually begin to progress in trials..
With data in July we could have seen the pps run to .40 with momentum.. and then shorted until a deal was done (which is what were waiting for now)..
Either way the END GAME will be the same..
Science will win in the end.. and we are only in the early stages..
Gerald's credibility will do just fine congruent with a steady pps rise.. lol
This game takes a thick skin..
In the end ambs will be truly valued on a multiple of revenue + a fair price for milestones on assets which eventually begin to progress in trials..
With data in July we could have seen the pps run to .40 with momentum.. and then shorted until a deal was done (which is what were waiting for now)..
Either way the END GAME will be the same..
Science will win in the end.. and we are only in the early stages..
Gerald's credibility will do just fine congruent with a steady pps rise.. lol
This game takes a thick skin..
(0)
(0)
